查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
忧郁症治疗的全球市场(2022年～2028年):各产品类型，各疾病，各地区的市场规模调查与预测
市场调查报告书
商品编码
1084055

忧郁症治疗的全球市场(2022年～2028年):各产品类型，各疾病，各地区的市场规模调查与预测

Global Depression Treatment Market Size study, By Product Type, By Disease (Major Depression, Persistent Depressive Disorder, Seasonal Affective Disorder, Situational Depression, Treatment-Resistant Depression, Others), & Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

全球忧郁症治疗的市场规模，预计在2022年～2028年的预测期间内以健全成长率成长。牵引市场的主要原因，有忧郁症的发生率上升，治疗精神状态的治疗方法和抗忧郁症药的需求高涨，医疗费增加等。可是，药物的副作用和治疗必要的间隔，阻碍预测期间的市场成长。还有精神障碍的经济负担增加和广泛的治疗选择的利用可能性，预计成为在预测期间内的市场需求的催化剂。

本报告提供全球忧郁症治疗市场调查，市场概要，市场的推动因素与阻碍因素的分析，市场机会，COVID-19影响，各市场区隔的市场分析，竞争情形，主要企业的简介等系统性资讯。

目录

第1章 摘要整理

第2章 全球忧郁症治疗市场:定义和范围

第3章 全球忧郁症治疗:市场动态

  • 忧郁症治疗市场:影响分析(2020年～2028年)

第4章 全球忧郁症治疗市场:产业分析

  • 波特的5力模式
  • PEST分析
  • 投资采用模式
  • 分析师的推荐事项与结论
  • 主要的投资机会
  • 主要的成功策略

第5章 风险评估:COVID-19影响

    • COVID-19对产业的整体影响的评估
    • COVID-19前及COVID-19后的市场情境

第6章 全球忧郁症治疗市场:各产品类型

  • 市场概述
  • 成果:潜力分析
  • 市场规模的估计与预测(2018年～2028年)
  • 子区隔分析
    • 药物
    • TMS设备

第7章 全球忧郁症治疗市场:各疾病

  • 市场概述
  • 成果:潜力分析
  • 市场规模的估计与预测(2018年～2028年)
  • 子区隔分析
    • 大忧郁症
    • 持续性抑忧郁症障碍
    • 季节性情动障碍(SAD)
    • 情形的忧郁症
    • 抗治疗性忧郁症
    • 其他

第8章 全球忧郁症治疗市场:地区分析

  • 地区市场概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲的概述
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 亚太地区的概述
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地区

第9章 竞争情形

  • 主要市场策略
  • 企业简介
    • Viatris (Mylan Pharmaceuticals Inc.)
    • Sunovion Pharmaceuticals
    • AbbVie Inc. (Allergan, Inc.)
    • Jubilant Generics Limited
    • Sanis Health Inc.
    • (Apotex Holdings, Inc.) Apotex Corporation
    • Alembic Pharmaceuticals Limited
    • Pfizer Inc.
    • BrainsWay Ltd.
    • Nexstim Plc

第10章 调查流程

Global Depression Treatment Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Depression is a health condition in which an individual's mood is elevated or lower which causes a loss of interest and persistent feeling of sadness. Depression treatment includes medication, consulting therapy, or a combination of both. The rising incidences of depression worldwide, the growing need for therapies and antidepressants for curing mental conditions, coupled with increasing healthcare expenditure are the primary factors excelling the global market demand. For instance, according to Statista analysis, in 2020, nearly 2.1 million cases of depression among senior citizens were registered in India. Also, the figure is anticipated to rise and reach around 5 million cases of depression among senior citizens. Accordingly, the rapidly growing cases of depression among the global population are accelerating the demand for depression treatment, which is augmenting the market growth around the world. However, adverse effects of drugs and necessary gaps in treatment impede the growth of the market over the forecast period of 2022-2028. Also, the rising economic burden of mental disorders and the availability of a wide range of treatment options are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Depression Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising prevalence of various depression and anxiety disorders, along with the availability of skilled professionals. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing population, as well as rising investment in the R&D activities for the development of antidepressant drugs, would create lucrative growth prospects for the Depression Treatment Market across the Asia-Pacific region.

Major market players included in this report are:

Viatris (Mylan Pharmaceuticals Inc.)

Sunovion Pharmaceuticals

AbbVie Inc. (Allergan, Inc.)

Jubilant Generics Limited

Sanis Health Inc.

(Apotex Holdings, Inc.) Apotex Corporation

Alembic Pharmaceuticals Limited

Pfizer Inc.

BrainsWay Ltd.

Nexstim Plc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Drugs

TMS Devices

By Disease:

Major Depression

Persistent Depressive Disorder

Seasonal Affective Disorder (SAD)

Situational Depression

Treatment-Resistant Depression

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Depression Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Depression Treatment Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Depression Treatment Market, by Product Type, 2020-2028 (USD Million)
    • 1.2.3. Depression Treatment Market, by Disease, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Depression Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Depression Treatment Market Dynamics

  • 3.1. Depression Treatment Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidences of depression worldwide
      • 3.1.1.2. Increasing healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of drugs and necessary gaps in treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising economic burden of mental disorders
      • 3.1.3.2. Availability of a wide-range of treatment options

Chapter 4. Global Depression Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Depression Treatment Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Depression Treatment Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Depression Treatment Market Estimates & Forecasts by Product Type, 2018-2028 (USD Million)
  • 6.4. Depression Treatment Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. TMS Devices

Chapter 7. Global Depression Treatment Market, by Disease

  • 7.1. Market Snapshot
  • 7.2. Global Depression Treatment Market by Disease, Performance - Potential Analysis
  • 7.3. Global Depression Treatment Market Estimates & Forecasts by Disease, 2018-2028 (USD Million)
  • 7.4. Depression Treatment Market, Sub Segment Analysis
    • 7.4.1. Major Depression
    • 7.4.2. Persistent Depressive Disorder
    • 7.4.3. Seasonal Affective Disorder (SAD)
    • 7.4.4. Situational Depression
    • 7.4.5. Treatment-Resistant Depression
    • 7.4.6. Others

Chapter 8. Global Depression Treatment Market, Regional Analysis

  • 8.1. Depression Treatment Market, Regional Market Snapshot
  • 8.2. North America Depression Treatment Market
    • 8.2.1. U.S. Depression Treatment Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Disease breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Depression Treatment Market
  • 8.3. Europe Depression Treatment Market Snapshot
    • 8.3.1. U.K. Depression Treatment Market
    • 8.3.2. Germany Depression Treatment Market
    • 8.3.3. France Depression Treatment Market
    • 8.3.4. Spain Depression Treatment Market
    • 8.3.5. Italy Depression Treatment Market
    • 8.3.6. Rest of Europe Depression Treatment Market
  • 8.4. Asia-Pacific Depression Treatment Market Snapshot
    • 8.4.1. China Depression Treatment Market
    • 8.4.2. India Depression Treatment Market
    • 8.4.3. Japan Depression Treatment Market
    • 8.4.4. Australia Depression Treatment Market
    • 8.4.5. South Korea Depression Treatment Market
    • 8.4.6. Rest of Asia Pacific Depression Treatment Market
  • 8.5. Latin America Depression Treatment Market Snapshot
    • 8.5.1. Brazil Depression Treatment Market
    • 8.5.2. Mexico Depression Treatment Market
  • 8.6. Rest of The World Depression Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Viatris (Mylan Pharmaceuticals Inc.)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Sunovion Pharmaceuticals
    • 9.2.3. AbbVie Inc. (Allergan, Inc.)
    • 9.2.4. Jubilant Generics Limited
    • 9.2.5. Sanis Health Inc.
    • 9.2.6. (Apotex Holdings, Inc.) Apotex Corporation
    • 9.2.7. Alembic Pharmaceuticals Limited
    • 9.2.8. Pfizer Inc.
    • 9.2.9. BrainsWay Ltd.
    • 9.2.10. Nexstim Plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Depression Treatment Market, report scope
  • TABLE 2. Global Depression Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Depression Treatment Market estimates & forecasts by Product Type 2018-2028 (USD Million)
  • TABLE 4. Global Depression Treatment Market estimates & forecasts by Disease 2018-2028 (USD Million)
  • TABLE 5. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Depression Treatment Market
  • TABLE 55. List of primary sources, used in the study of global Depression Treatment Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Depression Treatment Market, research methodology
  • FIG 2. Global Depression Treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Depression Treatment Market, key trends 2021
  • FIG 5. Global Depression Treatment Market, growth prospects 2022-2028
  • FIG 6. Global Depression Treatment Market, porters 5 force model
  • FIG 7. Global Depression Treatment Market, pest analysis
  • FIG 8. Global Depression Treatment Market, value chain analysis
  • FIG 9. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Depression Treatment Market, regional snapshot 2018 & 2028
  • FIG 15. North America Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Depression Treatment market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 19. Global Depression Treatment Market, company market share analysis (2021)